Skip to content
Search

Latest Stories

Trailer of Akshay Kumar starrer Laxmmi Bomb to be out tomorrow

Akshay Kumar starrer Laxmmi Bomb is one of the most awaited films of 2020. The movie was supposed to hit the big screens on Eid this year, but due to the pandemic that didn’t happen and later the makers decided to release it on the OTT platform Disney+ Hotstar.

A few days ago, it was announced that the movie will start streaming on Disney+ Hotstar on Diwali this year, and today, it has been revealed that the trailer of Laxmmi Bomb will be out tomorrow.


Akshay Kumar posted on Instagram, “Hassoge, darroge aur apne ghar valo ke sath milkar kal sab se bada dhamaka dekhoge! ?Watch #LaxmmiBomb Trailer, coming out tomorrow! #YeDiwaliLaxmmiBombWali! ? #FoxStarStudios #DisneyPlusHotstarMultiplex @kiaraaliaadvani @offl_lawrence @shabskofficial @tusshark89 @foxstarhindi @disneyplushotstarvip #CapeOfGoodFilms #ShabinaaEntertainment #TussharEntertainmentHouse @zeemusiccompany.”

Well, we are super excited to watch the trailer of Laxmmi Bomb as the posters have already impressed us a lot.

Directed by Raghava Lawrence, Laxmmi Bomb is a remake of Tamil film Muni 2: Kanchana. The Tamil film was also directed by Lawrence and he had also played the lead role in it. Laxmmi Bomb stars Kiara Advani as the female lead.

Reportedly, Akshay has planned a special strategy to promote the film. He will be promoting the movie at the ongoing Indian Premier League (IPL) and will also be appearing on Kapil’s show, The Kapil Sharma Show.

While in India Laxmmi Bomb will get a direct-to-digital release, it will be getting a theatrical release in Australia, New Zealand, and UAE.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less